Allogene Therapeutics (ALLO) Non Operating Income (2018 - 2026)
Allogene Therapeutics (ALLO) recorded Non Operating Income of $4.24 million in Q2 2026, down 27.8% from $5.88 million a year earlier but up 21.8% from the prior quarter.
Powered by 
Analysis
Allogene Therapeutics (ALLO) Non Operating Income (2018 - 2026) Analysis & Trends
On a TTM basis, Allogene Therapeutics' Non Operating Income came in at $14.82 million as of Jun 30, 2026, down 16.8% year-over-year; for FY2025, it was $18.43 million, up 14.8% from FY2024.
- Across earlier years, Non Operating Income came in at $16.05 million in FY2024, $472,000 in FY2023, -$4.88 million in FY2022 and -$1.86 million in FY2021.
- Quarterly Non Operating Income has ranged from -$3.67 million in Q2 2022 to $5.88 million in Q2 2025 over the past five years.
- On a year-over-year basis, Non Operating Income rose in four of the last seven quarters, with growth averaging 124.5%.
- Peak year-over-year performance for Non Operating Income in the last five years was growth of 673.1% in Q3 2024, against a decline of 36.1% in Q1 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $3.49 million (Q1 2026), $3.59 million (Q4 2025) and $3.5 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Allogene Therapeutics | 552.55 Mn | 552.55 Mn | - | 4.24 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.24 Mn |
| Mar 31, 2026 | 3.49 Mn |
| Dec 31, 2025 | 3.59 Mn |
| Sep 30, 2025 | 3.50 Mn |
| Jun 30, 2025 | 5.88 Mn |
| Mar 31, 2025 | 5.46 Mn |
| Dec 31, 2024 | 994,000.00 |
| Sep 30, 2024 | 5.48 Mn |
| Jun 30, 2024 | 5.07 Mn |
| Mar 31, 2024 | 4.50 Mn |
| Dec 31, 2023 | -669,000.00 |
| Sep 30, 2023 | 709,000.00 |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | -876,000.00 |
| Dec 31, 2022 | -880,000.00 |
| Sep 30, 2022 | -1.73 Mn |
| Jun 30, 2022 | -3.67 Mn |
| Mar 31, 2022 | 1.41 Mn |
| Dec 31, 2021 | -1.62 Mn |
| Sep 30, 2021 | -516,000.00 |
API Access
Allogene Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ALLO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ALLO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ALLO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();